|
End-of-day quote
NYSE
|
||
| - USD | - |
|
| 24/04/14 | PERNOD RICARD : looks for more bolt-on deals after U.S. buy | RE |
| 22/04/14 | Allergan : Activist investors see Ackman-Valeant deal as a model to follow | RE |
| Manager | Title | Age | Since |
|---|---|---|---|
Greg Hughes
CEO | Chief Executive Officer | - | 30/09/2023 |
Gina Rossi
DFI | Director of Finance/CFO | 54 | 31/03/2017 |
John Rosair
PRN | Corporate Officer/Principal | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | - | 31/12/2014 | |
Haruhisa Inada
BRD | Director/Board Member | - | 29/04/2014 |
Shingo Torii
BRD | Director/Board Member | 73 | 30/04/2014 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.98% | +2.50% | -5.63% | -26.26% | 249B | ||
| -1.82% | -1.81% | -40.09% | -55.76% | 42.44B | ||
| -2.39% | +2.74% | -34.50% | -45.22% | 22.34B | ||
| -2.57% | +0.88% | -28.29% | -61.07% | 19.51B | ||
| +0.59% | +1.51% | +18.16% | +54.07% | 11.41B | ||
| -2.38% | -0.64% | -41.94% | -70.36% | 9.06B | ||
| -0.76% | +0.67% | -8.83% | -48.64% | 8.38B | ||
| -1.06% | +8.37% | -32.52% | -62.24% | 6.96B | ||
| -0.93% | +9.17% | -25.28% | -48.05% | 5.5B | ||
| Average | -1.37% | +0.38% | -22.10% | -40.39% | 41.59B | |
| Weighted average by Cap. | -1.22% | -0.61% | -13.46% | -32.66% |
- Stock Market
- Stocks
- Stock
- Stock
Select your edition
All financial news and data tailored to specific country editions
















